Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: A positron emission tomography study with fluorine-18-labeled setoperone

Archives of General Psychiatry

Volumn 56, Issue 8, 1999, Pages 705-711

  Yatham, Lakshmi N ^a   Liddle, Peter F ^a   Dennie, Joelle ^a   Shiah, I Shin ^a,c   Adam, Michael J ^b   Lane, Carol J ^a   Lam, Raymond W ^a   Ruth, Thomas J ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b TRIUMF   (Canada)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DESIPRAMINE; FLUORINE 18; SEROTONIN 2 RECEPTOR; SETOPERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; FRONTAL CORTEX; HUMAN; MALE; OCCIPITAL CORTEX; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; RECEPTOR DENSITY; TEMPORAL CORTEX;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN; DEPRESSIVE DISORDER; DESIPRAMINE; DOWN-REGULATION; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; FRONTAL LOBE; HUMANS; OCCIPITAL LOBE; PYRIMIDINONES; RECEPTORS, SEROTONIN; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032793007     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.56.8.705     Document Type: Article

References (54)

1. Stahl SM. Antidepressants and mood stabilizers. In: Stahl SM, ed. Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. New York, NY: Cambridge University Press; 1996:131-166.
2. Maes M, Meltzer HY. The serotonin hypothesis of major depression. In: Bloom F, Kupfer D, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1995:933-944.
3. Smith KA, Cowen PJ. Serotonin and depression. In: Honig A, Van Praag HM, eds. Depression: Neurobiological, Psychopathological and Therapeutic Advances. New York, NY: John Wiley & Sons Inc; 1997:129-146.
4. Peroutka SJ, Snyder SH. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science. 1980;210:88-90.
5. 3H]spiroperidol by chronic treatment with the antidepressant amitriptyline. J Pharmacol Exp Ther. 1980;215:582-587.
6. Kellar KJ, Casio CS, Butler JA, Kurtzke RN. Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. Eur J Pharmacol. 1981;69:515-518.
7. Blackshear MA, Sanders-Bush E. Serotonin receptor sensitivity after acute and chronic treatment with mianserin. J Pharmacol Exp Ther. 1982;221:303-308.
8. 2 receptor-mediated head twitch behavior following antidepressant treatment to mice. Br J Pharmacol. 1984;83:235-242.
9. Sanders-Bush E, Breeding M, Knoth K, Tsutsumi M. Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system. Psychopharmacology. 1989;99:64-69.
10. Welner SA, De Montigny C, Desroches J, Desjardins P, Suranyi-Cadotte BE. Autoradiograprtic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment. Synapse. 1989;4:347-352.
11. Newman ME, Drummer D, Lerer B. Single and combined effects of desimipramine and lithium on serotonergic receptor number and second messenger function in rat brain. J Pharmacol Exp Ther. 1990;252:826-831.
12. 2-mediated behavior in the rat following noradrenergic or serotonergic denervation. J Neural Transm Gen Sect. 1991;84:19-32.
13. 2 receptors in the rat brain. J Psychiatr Neurosci. 1994;19:63-67.
14. 1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J Pharmacol Exp Ther. 1994;268:1432-1443.
15. Le Poul E, Lima L, Laporte AM, Even C, Doucet E, Fattaccini CM, Laaris N, Hamon M, Lanfumey L. Central serotonin receptors and chronic treatment with selective serotonin reuptake inhibitors in the rat: comparative effects of fluoxetine and paroxetine. Encephale. 1995;21:123-132.
16. 3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behavior. Psychopharmacology. 1983;80:150-155.
17. Wamsley JK, Byerley WF, McCabe RT, McConnell EJ, Dawson TM, Grosser BJ. Receptor alterations with serotonergic agents: an autoradiographic analysis. J Clin Psychiatry. 1987;48:19-25.
18. 2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment. J Pharmacol Exp Ther. 1988;246:956-962.
19. 2 receptors in rat brain: an autoradiographic study. Synapse. 1993;14: 324-331.
20. 2A receptors with positron emission tomography. Life Sci. 1996;58:187-192.
21. 11C]methyl)spiperone. Appl Radiat Isot, 1986;37:433-434.
22. 18F-setoperone. J Labeled Compounds Radiopharmaceuticals. 1988;25: 403-414.
23. 2 receptors in humans using positron emission tomography. Eur J Nucl Med. 1994;21: 937-946.
24. Crouzel C, Guillaume M, Barre L, Lemaire C, Pike VW. Ligands and tracers for PET studies of the 5-HT system: current status. Nucl Med Biol. 1992;19:857-870.
25. 2 receptors: implications for the therapeutics of schizophrenia. Am J Psychiatry. 1997;154:1525-1529.
26. 2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Am J Psychiatry. 1998;155:921-928.
27. 2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients. Am J Psychiatry. 1998;155:505-508.
28. 2A receptor density abnormality in the cortex of schizophrenic patients studied with PET. Schizophr Res. 1998;31:13-17.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
30. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview tor DSM-III-R, Patient Edition. Washington, DC: American Psychiatric Association; 1990.
31. Hamilton M. A rating scale of depression. J Neurol Neurosurg Psychiatry. 1960; 23:56-62.
32. Adam MJ, Lu S, Jivan S, Huser J. Simplified purification and synthesis of F-18 setoperone. J Labeled Compounds Radiopharmaceuticals. 1997;40:258.
33. Pietrzyk U, Herholz K, Fink G, Jacobs A, Mielke R, Slansky I, Würker M, Heiss WD. An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI, and CT brain studies. J Nucl Med. 1994;35:2011-2018.
34. 18F-labeled setoperone. J Neurochem. 1990;54:1744-1754.
35. Friston KJ, Frith CD, Liddle PF, Frackowiak RSJ. Comparing function (PET) images: the assessment of significant change. J Cereb Blood Flow Metab. 1991; 11:690-699.
36. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp. 1995;2:189-210.
37. 18F-setoperone in the normal human neocortex. J Nucl Med. 1999;40:25-32.
38. 2, F and t fields. Adv Appl Probability. 1994;26:13-42.
39. Stanley M, Mann JJ. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet. 1983;1:214-216.
40. 2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry. 1986;43:954-959.
41. 2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry. 1989;146:730-736.
42. 2 sites in cortex and amygdala. Brain Res. 1993;614:37-44.
43. 2 receptor changes in major depression. Biol Psychiatry. 1990;27:489-496.
44. 2 receptor blockade by SSRIs: nefazodone vs paroxetine. Biol Psychiatry. 1998; 43(suppl):18S-19S.
45. 1 recognition sites. J Recept Res. 1988;8:59-81.
46. 2 receptors in depression. Paper presented at: the 21st Collegium Internationale Neuro-Psychopharmacologicum (CINP) Congress; Glasgow, Scotland; July 13, 1998:278.
47. 2 and β-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry. 1990;47:1038-1047.
48. Crow TJ, Cross AJ, Cooper SJ, Deakin JFW, Poulter M, Lofthouse R, Corsellis JAN, Chambers DR, Blessed G, Perry EK, Perry RH, Tomlinson BE. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology. 1984; 23:1561-1569.
49. 2 receptor binding sites in depressed suicide victims. Brain Res. 1988;443:272-280.
50. 2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment. Brain Res. 1994;642:281-289.
51. Stockmeier CA, Dilley GE, Shapiro LA, Overholser JC, Thompson PA, Meltzer HY. Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology. 1997;16:162-173.
52. McKeith IG, Marshall EF, Ferrier IN, Armstrong MM, Kennedy WN, Perry RH, Perry EK, Eccleston D. 5-HT receptor binding in post-mortem brain from patients with affective disorder. J Affect Disord. 1987;13:67-74.
53. 2 receptors in depression. Psychiatr Res Neuroimag. 1992;45:227-237.
54. 2 receptor imaging in major depression: focal changes in orbito-insular cortex. Br J Psychiatry. 1997;171:444-448.